J

Jounce Therapeutics Inc
F:21J

Watchlist Manager
Jounce Therapeutics Inc
F:21J
Watchlist
Price: 1.71 EUR Market Closed
Market Cap: 89.2m EUR

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of 21J.

The Intrinsic Value is calculated as the average of DCF and Relative values:

21J Intrinsic Value
Not Available
Base Case Scenario
Compare 21J to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about 21J?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Jounce Therapeutics Inc

Current Assets 197.2m
Cash & Short-Term Investments 189.5m
Other Current Assets 7.7m
Non-Current Assets 15.3m
PP&E 12.3m
Other Non-Current Assets 3m
Current Liabilities 23.6m
Accounts Payable 2.1m
Accrued Liabilities 21.3m
Other Current Liabilities 178k
Non-Current Liabilities 5.9m
Other Non-Current Liabilities 5.9m
Efficiency

Free Cash Flow Analysis
Jounce Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Jounce Therapeutics Inc

Revenue
82m USD
Operating Expenses
-134.2m USD
Operating Income
-52.2m USD
Other Expenses
1.3m USD
Net Income
-50.9m USD
Fundamental Scores

21J Profitability Score
Profitability Due Diligence

Jounce Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ROIC is Increasing
ROE is Increasing
Low 3Y Average Gross Margin
Low Gross Margin
hidden
Profitability
Score

Jounce Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

21J Solvency Score
Solvency Due Diligence

Jounce Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
hidden
Solvency
Score

Jounce Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

21J Price Targets Summary
Jounce Therapeutics Inc

There are no price targets for 21J.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for 21J is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y